(Q44620794)

4 December 2017

Efficacy of alendronate in adults with cystic fibrosis with low bone density (English)

1 reference

4 December 2017

Efficacy of Alendronate in Adults with Cystic Fibrosis with Low Bone Density (English)

1 reference

https://api.crossref.org/works/10.1164/RCCM.200307-1049OC

22 March 2024

0 references

Melissa Caminiti

3

1 reference

4 December 2017

Margaret Hensler

5

1 reference

4 December 2017

Ursula Guillen

9

1 reference

4 December 2017

Worakij Chalermskulrat

12

1 reference

4 December 2017

Robert M. Aris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

Gayle E. Lester

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

A. Denene Blackwood

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

Robert K. Lark

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

Travis M. Hecker

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

Jordan B. Renner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

Sue A. Brown

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

Isabel P. Neuringer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

David A. Ontjes

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14563654

22 March 2024

language of work or name

English

0 references

publication date

16 October 2003

1 reference

full work available at URL

4 December 2017

https://www.atsjournals.org/doi/pdf/10.1164/rccm.200307-1049OC

1 reference

https://api.crossref.org/works/10.1164/RCCM.200307-1049OC

American Journal of Respiratory and Critical Care Medicine

22 March 2024

published in

1 reference

4 December 2017

169

1 reference

4 December 2017

1

1 reference

4 December 2017

77-82

1 reference

Osteopenia in adults with cystic fibrosis

4 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Bone demineralization in cystic fibrosis: evidence of imbalance between bone formation and degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Altered calcium homeostasis in adults with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Low bone mineral density in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Histomorphometric analysis of bone biopsies from the iliac crest of adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

A prospective study of change in bone mineral density over one year in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Kyphosis and fractures in children and young adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Abnormal bone turnover in cystic fibrosis adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Bone density and fracture risk in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Effect of intravenous pamidronate on bone mineral density in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Osteoporosis in lung transplantation candidates with end-stage pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Alendronate for the Treatment of Osteoporosis in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Severe osteoporosis before and after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Bone density in children and adolescents with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Severe bone pain after intravenous pamidronate in adult patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Oral corticosteroids and bone pain after pamidronate in adults with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200307-1049OC

Demineralization in cystic fibrosis detected by direct photon absorptiometry

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1164/RCCM.200307-1049OC

Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients

22 March 2024

11

1 reference

https://api.crossref.org/works/10.1164/RCCM.200307-1049OC

Epidemiology of vertebral fractures in women

22 March 2024

23

1 reference

https://api.crossref.org/works/10.1164/RCCM.200307-1049OC

22 March 2024

Identifiers

1 reference

4 December 2017

1 reference